PT  - JOURNAL ARTICLE
AU  - J. P. PERKINS
AU  - G. HILLMAN
AU  - D. FISCHER
AU  - J. R. BERTINO
TI  - Antibody to Dihydrofolate Reductase from a Methotrexate-Resistant Subline of the L1210 Lymphoma
DP  - 1969 May 01
TA  - Molecular Pharmacology
PG  - 213--218
VI  - 5
IP  - 3
4099  - http://molpharm.aspetjournals.org/content/5/3/213.short
4100  - http://molpharm.aspetjournals.org/content/5/3/213.full
SO  - Mol Pharmacol1969 May 01; 5
AB  - An antiserum has been prepared against dihydrofolate reductase (EC 1.5.1.3) from mouse L1210 R tumor cells by injection of the purified enzyme into rabbits. The antiserum both precipitates and inactivates the enzyme; the antigen-antibody interaction fixes complement. The antibody inactivates dihydrofolate reductase from L5178Y, Ehrlich ascites carcinoma, and Sarcoma 180 murine tumors as well as that from the L1210 lymphoma. It partially inactivates enzyme from human bone marrow, but does not inactivate enzyme from Escherichia coli or from mouse, chicken, guinea pig, or rabbit liver. The cofactor NADPH, the substrates dihydrofolate and folate, and the inhibitor methotrexate protect the enzyme from inactivation by the antibody at low concentration.